SavedAdd your journal

Journals / Molecular Imaging and Radionuclide Therapy / 2015 / Cilt: 24 - Sayı: 0

Soliter Beyin Metastazının Saptanmasından Sonra FDG PET/BT ile Primer Kolon Karsinomu Gösterilen Bir Olgu

A Case of Primary Colon Carcinoma Demonstrated by FDG PET/CT Imaging After Detection of a Solitary Brain Metastasis

SEVAL ERHAMAMCI
Mehmet REYHAN
GÜL NİHAL NURSAL
NEŞE TORUN
Ali Fuat YAPAR
Pages
13–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This case indicates that FDG PET/CT imaging may have a positive impact on the evaluation of patients with brain metastasis from an unknown primary

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The detection of brain metastases as the initial manifestation of colorectal carcinoma without liver or lung involvement is extremely rare.
📊
Key Findings & Data:Herein we present a case of a 52-year-old male patient with an unusual presentation of colon cancer, with primary lesions demonstrated by fluorine-18-labeled fluorodeoxyglucose (FDG) Positron-emission tomography/computed tomography (PET/CT) after detection of a solitary brain metastasis.
💡
Conclusion & Impact:This case indicates that FDG PET/CT imaging may have a positive impact on the evaluation of patients with brain metastasis from an unknown primary
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The detection of brain metastases as the initial manifestation of colorectal carcinoma without liver or lung involvement is extremely rare. Herein we present a case of a 52-year-old male patient with an unusual presentation of colon cancer, with primary lesions demonstrated by fluorine-18-labeled fluorodeoxyglucose (FDG) Positron-emission tomography/computed tomography (PET/CT) after detection of a solitary brain metastasis. Brain CT images revealed a brain tumor. Histopathologic evaluation indicated metastatic poorly differentiated adenocarcinoma, while his physical examination was normal. The PET/CT revealed abnormal intense FDG uptake in the right parietal region and in descending colon, with no other abnormal FDG uptake elsewhere in the body. The histopathologic diagnosis of the descending colon lesion revealed moderately differentiated adenocarcinoma. This case indicates that FDG PET/CT imaging may have a positive impact on the evaluation of patients with brain metastasis from an unknown primary

Özet

Karaciğer veya akciğer tutulumu olmaksızın kolorektal karsinomunun ilk klinik bulgusu olarak beyin metastazının görülmesi son derece nadirdir. Burada, soliter beyin metastazının saptanmasından sonra, primer lezyonu flor-18-işaretli fluorodeoksiglukoz (FDG) Pozitron-emisyon tomografi/bilgisayarlı tomografi (PET/BT) ile gösterilen nadir kolon kanserli 52 yaşında erkek bir olguyu sunduk. Beyin BT görüntülerinde, beyin tümörü saptandı. Histopatholojik inceleme metastatik az diferansiye adenokarsinomayı gösterdi. Fizik muayene normaldi. PET/BT sağ parietal bölgede ve inen kolonda yoğun FDG tutulumu gösterdi, vücudun başka bir yerinde anormal FDG tutulumu izlenmedi. İnen kolondaki lezyonun histopatolojik tanısı orta diferansiye adenokarsinoma ile uyumluydu. Bu olgu, FDG PET/BT görüntülemenin primeri bilinmeyen beyin metastazlı hastaların değerlendirilmesinde olumlu etkiye sahip olabileceğini gösterdi

🔖

Cite This Article

ERHAMAMCI, S., REYHAN, M., NURSAL, G. N., TORUN, N., YAPAR, A. F. (2015). Soliter Beyin Metastazının Saptanmasından Sonra FDG PET/BT ile Primer Kolon Karsinomu Gösterilen Bir Olgu. Molecular Imaging and Radionuclide Therapy, Cilt: 24 - Sayı: 0, 13–15. https://ajindex.com/articles/295252

References (11)

  1. Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002;15:2698-2705.
  2. Kruser TJ, Chao ST, Elson P, Barnett GH, Vogelbaum MA, Angelov L, Weil RJ, Pelley R, Suh JH. Multidisciplinary management of colorectal brain metastases: A retrospective study. Cancer 2008;113:158-165.
  3. Kwee TC, Basu S, Cheng G, Alavi A. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010;37:635-644.
  4. Yapar Z, Kibar M, Yapar AF, Paydas S, Reyhan M, Kara O, Buyukdereli G, Aydin M, Kelle AP, Unal I, Disel U, Yavuz S, Sahin B, Erkisi M. The value of 18F-fluorodeoxyglucose positron emission tomography/ computed tomography in carcinoma of an unknown primary: diagnosis and follow-up. Nucl Med Commun 2010;31:59-66.
  5. Pelosi E, Pennone M, Deandreis D, Douroukas A, Mancini M, Bisi G. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site. Q J Nucl Med Mol Imaging 2006;50:15-22.
  6. Karapolat I, Kumanlıoğlu K. Impact of FDG-PET/CT for the Detection of Unknown Primary Tumours in Patients with Cervical Lymph Node Metastases. Mol Imaging Radionucl Ther 2012;21:63-68.
  7. Jenkinson MD, Haylock B, Shenoy A, Husband D, Javadpour M. Management of cerebral metastasis: evidence-based approach for surgery, stereotactic radiosurgery and radiotherapy. Eur J Cancer 2011;47:649-655.
  8. Mongan JP, Fadul CE, Cole BF, Zaki BI, Suriawinata AA, Ripple GH, Tosteron TD, Pipas JM. Brain metastases from colorectal cancer: risk factors, incidence, and the possible role of chemokines. Clin Colorectal Cancer 2009;8:100-105.
  9. Agazzi S, Pampallona S, Pica A, Vernet O, Regli L, Porchet F, Villemure JG, Leyvraz S. The origin of brain metastases in patients with an undiagnosed primary tumour. Acta Neurochir (Wien) 2004;146:153- 157. Bartelt S, Lutterbach J. Brain metastases in patients with cancer of unknown primary. J Neurooncol 2003;64:249-253.
  10. Linskey ME, Andrews DW, Asher AL, Burri SH, Kondziolka D, Robinson PD, Ammirati M, Cobbs CS, Gaspar LE, Loeffler JS, McDermott M, Mehta MP, Mikkelsen T, Olson JJ, Paleologos NA, Patchell RA, Ryken TC, Kalkanis SN. "The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline," J NeuroOncol 2010;96:45-68.
  11. Succi L, Urrico GS,